NanoViricides, Inc. (stock symbol: NNVC.OB) is working in the general field of Nanomedicine. This is a very diverse field and encompasses a wide range of materials and applications. Specifically, we are working in the area of targeted anti-viral therapeutics. Utilizing nanoscale materials and processes licensed from TheraCour Pharma, Inc., we are developing anti-viral drugs against a wide range range of human and animal viruses.
HIV
NanoViricides, Inc.
135 Wood Street
Suite. 205
West Haven, CT
06516
USA
Idenix Pharmaceuticals
60 Hampshire Street
Cambridge, MA
02139
USA
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases. The company developed Tyzeka/Sebivo through a co development agreement with Novartis Pharma AG for the treatment of patients with chronic hepatitis B in the United States and European Union for the treatment of patients with chronic hepatitis B.